Social Anxiety Disorder (SAD) Clinical Trial
Official title:
Nefazodone in the Treatment of Social Phobia: Functional Brain Imaging and Neuroendocrine Correlates
The purpose of this study is to determine the effectiveness of nefazadone in patients with social anxiety disorder (SAD).
The purpose of this study is to examine the efficacy of the 5HT2 receptor antagonist nefazadone in SAD, and to explore regional cerebral blood flow in patients with SAD when confronted with a personal phobic stimulus, using positron emission tomography (PET). Changes in cerebral blood flow were correlated with self-rated anxiety measures. ;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06037668 -
A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder.
|
N/A |